TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06587594

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Solution Focused Brief Therapy
Description: A behavioral health intervention designed to help autistic adults to make a positive change in their life using strength-based approach.
Study: NCT06591065

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga Flow
Description: The study participants were subjected to an intervention comprising hatha yoga sessions conducted twicw weekly over an twelve weeks period, with each session lasting 60 minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Controlled
Description: The control group did not receive any yoga training
Study: NCT06603935

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: QHSLab Digital Tools (AME and ARIS)
Description: Participants will use the QHSLab digital platform, which includes two tools: the Allergy Management Evaluation (AME) and the Allergic Rhinitis Intervention Steps (ARIS). The AME provides a comprehensive digital assessment for identifying and monitoring allergic rhinitis symptoms. The ARIS offers personalized feedback based on patient-reported outcomes and continuously adjusts treatment recommendations through an algorithm. These tools support better symptom management, adherence to medication, and overall improvement in quality of life.
Study: NCT06585917

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 7F Thin-Walled Sheath
Description: The 7F Thin-Walled Sheath is used during coronary intervention procedures via distal radial artery access. This device has a smaller outer diameter compared to traditional 7F sheaths, designed to reduce the risk of vascular complications while allowing for the performance of complex coronary interventions.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 6F Thin-Walled Sheath
Description: The 6F Thin-Walled Sheath is the standard device used in coronary intervention procedures via distal radial artery access. It is employed as a control in this study to compare its efficacy and safety against the 7F Thin-Walled Sheath.
Study: NCT06599307

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Rituximab 1gm vial diluted on 500 ml normal saline 0.9%

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline (NaCl 0,9 %) (placebo)
Description: 500 ml of normal saline 0.9%
Study: NCT06591052

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Passive stretching
Description: The physiotherapist positioned each muscle in its maximum lengthened state and held it there for 30 seconds. This process was repeated three times, with a 30-second rest interval between each stretch of the different muscle groups.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PNF stretching
Description: The physiotherapist initially positioned each muscle in its most extended state, similar to the positions used in passive stretching. In this extended position, the participants performed an isometric contraction against maximal resistance in the antagonist direction for 5-8 seconds. Following the isometric contraction, participants were instructed to actively relax, and after a 5-second waiting period to ensure complete relaxation, the movement range was passively increased. The new end point of the extended range of motion was held for 30 seconds. This stretching protocol was repeated three times for each muscle group, with a 30-second rest period between each stretch.
Study: NCT06591832

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Virtual reality based progressive relaxation exercise
Study: NCT06587178

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: peptison liquid
Description: CD patients requiring bowel resection and preoperative EEN were randomized to receive peptison liquid for 6 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Enteral nutritional suspension
Description: CD patients requiring bowel resection and preoperative EEN were randomized to receive enteral nutritional suspension for 6 weeks.
Study: NCT06597214

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AVACore Technologies, Inc. warmUP Sleeve
Description: AVAcore Technologies's warmUP (WU-20) Temperature Management System was developed based on work with the Aquarius Medical Acrotherm device and prior human hypothermic subject data showing a rewarming rate of \~1ºC in 5 minutes when heat and vacuum application was tested. AVAcore Technologies received FDA acceptance of its Section 510(k) premarket notification for the warmUP (vH1) Temperature Management System in 2005. This product was used on over 100 patients in the US in 2005-2006 timeframe.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Arizant Healthcare Bair Hugger®
Description: The Arizant Healthcare Bair Hugger® Temperature Management System proposed for use in this study is a 'forced air' system providing convective warming via the circulation of warmed air through a specially designed blanket which is placed over a portion of the patient's body. This product has been in use in the US for over 20 years in a majority of hospitals.
Study: NCT06596408

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: optical coherence tomography angiography
Description: OCTA will be used to evaluate the macular vascular density and to exclude patients with pathological myopic maculopathy
Study: NCT06594666

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VR/AR visual training group
Description: Wear glasses for correction combined with VR/AR visual training in the first 6 months, and terminate the training for follow-up observation in the last 6 months. Regular follow-up every 3 months, with a total follow-up time of 1 year.
Study: NCT06594835

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Better Together
Description: Better Together (BT) is a 90-min, age-appropriate, culturally relevant prevention intervention to prevent substance use among Black youth experiencing household challenges (ages 11-13) by addressing the multilevel influences of substance use.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Youth In the Media (YM)
Description: Delivered in eight in-person, 90-minute sessions concurrently with BT sessions, the YM program was designed to (1) increase participants' awareness of and access to the different types of media and free resources available at the participants local libraries, (2) discuss different types of media that center stories and experiences of Black youth, and (3) expose participants to careers in media.
Study: NCT06593925

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Production of polyoxymethylene telescopic denture
Description: Remaining teeth will be prepared by conventional grinding technique, followed by impression, casting and scanning with extra oral scanner. Inner telescopic crowns will be made of cobalt-chromium alloy by milling technique and outer crowns together with denture framework will be made of polyoxymethylene by the method of single phase injection moulding. Denture delivery is done by inserting both inner and outer crown at the same time, during which the inner crown is cemented to the abutment tooth and the contact surfaces of the outer and inner crown are isolated so that the outer crown and denture framework can be removed.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Production of conventional complex partial denture with clasps
Description: A conventional complex partial denture is a removable partial denture with clasps combined with metal-ceramic surveyed crowns with milled surfaces for removable dentures. The metal-ceramic surveyed crowns are shaped in such a way that they build a morphological and functional whole with complementary elements of the removable partial denture's framework. In the control group, as well as in the experimental group, the remaining teeth are prepared using a conventional grinding technique, then an impression is taken for dedicated metal-ceramic crowns, casting, and milling of crowns, ceramic sintering, impression through the metal-ceramic surveyed crowns and fabrication of a removable partial denture's framework with clasps using the casting method. Dedicated fixed restorations will be made of Co-Cr alloy inside the crown and ceramic layer on the surface, and the framework and clasps of the removable partial denture will be made of Co-Cr-Mo alloy.
Study: NCT06593470

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MINDS-UP
Description: MINDS-UP is a substance use prevention program for children/adolescents.It consists of 4 x 60-minute sessions, once weekly over 4 weeks. The four MINDS-UP classes will focus on the following: Mindfulness of Body; Mindfulness of Mind; Mindfulness of Environment/Community; Kindness, Compassion, Joy and Equanimity, respectively.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MINDS-UP
Description: MINDS-UP is a substance use prevention program for children/adolescents.It consists of 4 x 60-minute sessions, once weekly over 4 weeks. The four MINDS-UP classes will focus on the following: Mindfulness of Body; Mindfulness of Mind; Mindfulness of Environment/Community; Kindness, Compassion, Joy and Equanimity, respectively.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prevention Plus Wellness
Description: PPW is a standardized, empirically-based intervention for substance use prevention in adolescents ages 10-14. It consists of 1 45-60 minute session between an adolescent and a trained PPW teacher.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prevention Plus Wellness
Description: PPW is a standardized, empirically-based intervention for substance use prevention in adolescents ages 10-14. It consists of 1 45-60 minute session between an adolescent and a trained PPW teacher.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Prevention Plus Wellness
Description: PPW is a standardized, empirically-based intervention for substance use prevention in adolescents ages 10-14. It consists of 1 45-60 minute session between an adolescent and a trained PPW teacher.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: fMRI
Description: Functional MRI to investigate preliminary neural mechanisms of MINDS-UP
Study: NCT06597409

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard PR
Description: (Aerobic exercise, PLB, ACBT, Education)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard PR plus Respiratory Muscle Stretching (RMS)
Description: Standard PR plus Respiratory Muscle Stretching (RMS)
Study: NCT06596109

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: honey intake and lifestyle changes
Description: Twenty fatty liver (non-alcoholic from) patients with obesity are included as 20 patients who will receive natural unprocessed honey intake (orally, as a daily total dose of 2 g/kg, this dose will be divided to three equal subdoses, every dose will be administered before meal), low calorie diet, and treadmill walking (40 minutes per session, three times per week) for 12 weeks.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: lifestyle changes
Description: Twenty fatty liver (non-alcoholic from) patients with obesity are included as 20 patients who will receive low calorie diet and treadmill walking (40 minutes per session, three times per week) for 12 weeks.
Study: NCT06600607

Intervention type: DRUG
Group type: OTHER
Intervention: pregabalin 300 mg
Description: pregabalin is an FDA-approved anticonvulsant medication commonly used to treat nerve pain

Intervention type: DRUG
Group type: OTHER
Intervention: pregabalin 300 mg
Description: pregabalin is an FDA-approved anticonvulsant medication commonly used to treat nerve pain

Intervention type: OTHER
Group type: OTHER
Intervention: Placebo
Description: biologically inactive placebo comparator

Intervention type: OTHER
Group type: OTHER
Intervention: Placebo
Description: biologically inactive placebo comparator
Study: NCT06597981

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dyadic empowerment-based sport stacking
Description: For the intervention group, the care dyads will receive an 18-week dyadic empowerment-based sport stacking program, which is divided into two phases: the active phase (weeks 1-12) and the maintenance phase (weeks 13-18). In the active phase, the care dyads will engage in three online sessions in small groups (3-5 dyads/group) and three check-up/support sessions. Three online sessions will be scheduled at weeks 1, 3, and 9 during the 12-week active phase. They will also be required to engage in self-practice at home for at least 30 minutes per day, five times per week during this time according to their training schedule. In the maintenance phase, there will be three online sessions in small groups (3-5 dyads/group). Three online sessions will be scheduled at weeks 13, 16, and 18. The dyads will continue their self-practice at home (at least 30 minutes/day, five times/week) for 6 weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Basic education
Description: Participants in the control group will receive basic education on dementia caregiving, which will comprise three group-based (3-5 dyads/group) online meetings in the same schedule as the intervention group (1st, 3rd, 9th week).
Study: NCT06051890

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Extended-Release Buprenorphine (XRB)
Description: XRB (Sublocade) will be delivered as a pre-filled 2cc subcutaneous monthly injection, using a 300mg starting dose in most cases (100mg starting doses are available per the study team's clinical judgement). XRB consists of a depot injectable formulation in polymeric solution to the abdomen and releases buprenorphine over 28-days (4-weeks) by diffusion as the polymer biodegrades. Prior to an initial injection, the participant must be stable for several days or longer on sublingual buprenorphine (SLB) at doses of 8mg/day or higher. Participants will receive at least one XRB monthly injection prior to release, which investigators anticipate to usually be the 300mg dose. Some participants will be recruited earlier during the incarceration (or experience delayed release dates and then longer than anticipated incarcerations); XRB will be continued monthly from the time of induction to the day of release.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sublingual Buprenorphine (SLB)
Description: Maintenance of existing SLB prescription (treatment as usual).
Study: NCT06203327

Intervention type: OTHER
Intervention: Esophagogastroscopy (OLGA 0-Ⅰ)
Description: Surveillance endoscopies at years 3-5.

Intervention type: OTHER
Intervention: Esophagogastroscopy (OLGA II)
Description: Surveillance endoscopies at years 2-3.
Study: NCT06463561

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure
Description: Treatment will start with an empirical pressure of 8 cmH2O and, within a maximum of 3 weeks, the pressure will be adjusted by means of automatic titration, establishing the pressure corresponding to the 95th percentile.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hygienic-dietary recommendations and daily physical activity promotion
Description: Hygienic-dietary recommendations on sleep and intervention for the promotion of daily physical activity, establishing walking as a goal 10,000 steps per day. To do this, they will be provided with a pedometer and asked to fill out a form with the steps walked each day. At each visit, the distance walked will be reviewed and the goal set will be reiterated.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Hygienic-dietary recommendations and daily physical activity promotion
Description: Hygienic-dietary recommendations on sleep and intervention for the promotion of daily physical activity, establishing walking as a goal 10,000 steps per day. To do this, they will be provided with a pedometer and asked to fill out a form with the steps walked each day. At each visit, the distance walked will be reviewed and the goal set will be reiterated.
Study: NCT04780477

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: High Fiber Diet Featuring Legumes (HLD)
Description: The high fiber diet featuring legumes (HLD) provides pre-portioned entrées for two meals per day in months 1-3, and one meal per day in months 4-6. Participants continue on the diet in months 7-12 but assume responsibility for food preparation. The HLD will contain approximately 250 grams (g) of legumes per day (\~1 ½ cups cooked legumes) in months 1-3 provided in two pre-portioned single serving entrées (i.e. \~125g in each serving). A study nutritionist provides in-person and written guidance for including side dishes that are nutritionally balanced with energy intake to lose 1-2 pounds of weight per week.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Healthy American Diet
Description: The healthy American diet provides pre-portioned meal replacement entrées with legumes replaced by lean chicken or meat. Participants continue on the diet in months 7-12 but assume responsibility for food preparation. A study nutritionist provides in-person and written guidance for including side dishes that are nutritionally balanced with energy intake to lose 1-2 pounds of weight per week.
Study: NCT01241175

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Magnesium Sulfate

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Study: NCT06037473

Intervention type: DRUG
Intervention: Polyethylene glycol recombinant human growth hormone injection
Description: 0.1-0.3mg/kg.w

Intervention type: DRUG
Intervention: Polyethylene glycol recombinant human growth hormone injection
Description: 0.1-0.3mg/kg.w

Intervention type: DRUG
Intervention: Polyethylene glycol recombinant human growth hormone injection
Description: 0.1-0.3mg/kg.w

Intervention type: DRUG
Intervention: Polyethylene glycol recombinant human growth hormone injection
Description: 0.1-0.3mg/kg.w

Intervention type: DRUG
Intervention: Polyethylene glycol recombinant human growth hormone injection
Description: 0.1-0.3mg/kg.w
Study: NCT04793841

Intervention type: OTHER
Intervention: self-sampling kits for STI testing in laboratory
Description: participants in both groups will receive self-sampling kits and deliver the collected samples to laboratory for testing

Intervention type: OTHER
Intervention: self-sampling kits for STI testing in laboratory
Description: participants in both groups will receive self-sampling kits and deliver the collected samples to laboratory for testing
Study: NCT05600296

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levobupivacaine
Description: Evaluation the postoperative analgesic effects by using ultrasound-guided spermatic cord block (SCB) and IINB in children scheduled for elective open inguinal herniotomy. The study hypothesized that, the combined block with SCB and IINB would result in more effective postoperative analgesia than the use of IINB alone.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levobupivacaine
Description: Evaluation the postoperative analgesic effects by using ultrasound-guided spermatic cord block (SCB) and IINB in children scheduled for elective open inguinal herniotomy. The study hypothesized that, the combined block with SCB and IINB would result in more effective postoperative analgesia than the use of IINB alone.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ilioinguinal/iliohypogastric nerve block (IINB)
Description: Ilioinguinal/iliohypogastric nerve block (IINB)

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: IINB+ Spermatic cord block
Description: IINB+ Spermatic cord block
Study: NCT05690113

Intervention type: PROCEDURE
Intervention: CATS scale
Description: During the inclusion visit (J0), enrolled children will complete the CATS scale as well as the SCARED (Screen for Child Anxiety and Related Disorders). Their parents will also complete the CATS and the SDQ (Strength and Difficulties Questionnaire).

Intervention type: PROCEDURE
Intervention: CATS scale
Description: During the inclusion visit (J0), enrolled children will complete the CATS scale as well as the SCARED (Screen for Child Anxiety and Related Disorders). Their parents will also complete the CATS and the SDQ (Strength and Difficulties Questionnaire).
Study: NCT05985421

Intervention type: OTHER
Intervention: Fecal collection
Description: approximate volume of 2 ml

Intervention type: OTHER
Intervention: Fecal collection
Description: approximate volume of 2 ml

Intervention type: OTHER
Intervention: Blood sampling
Description: 1 EDTA tube (7 ml) to test for chronic low-grade inflammation + 1 EDTA tube (7 ml) to test for intestinal inflammation, digestive permeability and microbial translocation

Intervention type: OTHER
Intervention: Blood sampling
Description: 1 EDTA tube (7 ml) to test for chronic low-grade inflammation + 1 EDTA tube (7 ml) to test for intestinal inflammation, digestive permeability and microbial translocation

Intervention type: OTHER
Intervention: Polysomnography
Description: Polysomnography

Intervention type: OTHER
Intervention: Polysomnography
Description: Polysomnography

Intervention type: OTHER
Intervention: Auto questionnaires
Description: International RLS Study Group Severity Scale, Epworth Sleepiness Scale, Insomnia Severity Index, Beck Depression Inventory-II, Autonomic symtoms scale (SCOPA-AUT)

Intervention type: OTHER
Intervention: Auto questionnaires
Description: International RLS Study Group Severity Scale, Epworth Sleepiness Scale, Insomnia Severity Index, Beck Depression Inventory-II, Autonomic symtoms scale (SCOPA-AUT)
Study: NCT04845243

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Emotionen Verstehen und Ausdrücken (E.V.A.)
Description: The online training is focused on the strengthening of socioemotional competences and consists of different training tasks (up to 3 million) presented to the participant as mini games. These training tasks are specifically designed according to empirical findings to match the socio-emotional recognition needs of people with ASD. During these games, an adapted Elo-Algorithm allows to automatically evaluate the participants' performance and adapts the difficulty levels throughout the users' progress in the training.
Study: NCT06206252

Intervention type: OTHER
Intervention: Medical Cannabis
Description: Participants will be restricted to specific medical cannabis products from Ethos Dispensary. They will be randomized to one medical cannabis formulation (tincture or vaporization) for the duration of the study. Each month for three months, they will purchase a different composition (predominantly THC, predominantly CBD, or balanced products) of their designated formulation. The order of compositions will be randomized and double-blinded, so participants and the research team will not know which compositions of medical cannabis they are using each month.
Study: NCT06203327

Intervention type: OTHER
Intervention: Esophagogastroscopy (OLGA III-IV)
Description: Surveillance endoscopies every year.